This IDC Perspective is a regular quarterly review of notable news in the life sciences. It is intended to highlight signposts of both progress in ongoing industry trends and early indications of industry transformation.
"There are clear indicators of progress as the life science industry advances its efforts to regain long-term sustainability and bring new treatments and cures for disease. As expected, progress can be uneven and some medical unmet needs remain highly intransigent to progress. The role of technology in the life sciences remains supportive and, despite its historical resistance to change, companies are evaluating and adopting scientific and technological innovation at an unprecedented rate. With the life sciences as an increasingly competitive and global venture, it is critical that companies stay on top of leading trends to ensure that they don't fall behind or miss promising opportunities. This document is intended to be a quick read and a regular, independent third-party review of industry progress." — Alan S. Louie, research director, IDC Health Insights Life Science R&D Strategies and Technologies.